Atyr Pharma Inc [LIFE] Stock sold by Insider Broadfoot Jill Marie for $2687.0

Atyr Pharma Inc’s filing revealed that its Chief Financial Officer Broadfoot Jill Marie unloaded Company’s shares for reported $2687.0 on Feb 06 ’24. In the deal valued at $1.69 per share,1,590 shares were sold. As a result of this transaction, Broadfoot Jill Marie now holds 20,821 shares worth roughly $33730.020000000004.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Then, Shukla Sanjay bought 12,000 shares, generating $14,136 in total proceeds. Upon buying the shares at $1.18, the President and CEO now owns 106,173 shares.

Before that, Shukla Sanjay bought 3,000 shares. Atyr Pharma Inc shares valued at $3,510 were divested by the President and CEO at a price of $1.17 per share. As a result of the transaction, Shukla Sanjay now holds 94,173 shares, worth roughly $0.15 million.

Oppenheimer downgraded its Atyr Pharma Inc [LIFE] rating to a Perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in mid October with a ‘”an Outperform”‘ rating. Piper Sandler began covering LIFE with “an Overweight” recommendation on September 21, 2021. Laidlaw started covering the stock on May 10, 2021. It rated LIFE as “a Buy”.

Price Performance Review of LIFE

On Tuesday, Atyr Pharma Inc [NASDAQ:LIFE] saw its stock jump 1.25% to $1.62. Over the last five days, the stock has lost -2.99%. Atyr Pharma Inc shares have risen nearly 14.89% since the year began. Nevertheless, the stocks have fallen -16.49% over the past one year. While a 52-week high of $2.70 was reached on 02/20/24, a 52-week low of $1.08 was recorded on 01/02/24. SMA at 50 days reached $1.6961, while 200 days put it at $1.6856. A total of 0.43 million shares were traded, compared to the trading of 0.47 million shares in the previous session.

Levels Of Support And Resistance For LIFE Stock

The 24-hour chart illustrates a support level at 1.5833, which if violated will result in even more drops to 1.5467. On the upside, there is a resistance level at 1.6433. A further resistance level may holdings at 1.6667. The Relative Strength Index (RSI) on the 14-day chart is 40.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1895, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.20%. Stochastics %K at 6.15% indicates the stock is a buying.

How much short interest is there in Atyr Pharma Inc?

A steep rise in short interest was recorded in Atyr Pharma Inc stocks on Feb 29, 2024, growing by 8820.0 shares to a total of 0.11 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 99410.0 shares. There was a rise of 8.15%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 0.27% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.18.

Most Popular